{"text": "URL &lt;&lt; top stock pick services fully reviewed! $fb $baba $gild $sbux"}
{"text": "rt AT_USER 'AT_USER tells us he's not looking at gilead $gild"}
{"text": "earlier on fast money, icahn denied $gild activism rumors"}
{"text": "4 things gilead sciences' ceo says to expect in 2017 $gild URL"}
{"text": "rt AT_USER gilead sciences - top biotech pick for the next decade URL $gild"}
{"text": "top money flow nasdaq 100: $gild $ctsh $goog $ebay $ctxs $amzn $celg $pcln $symc $xlnx URL"}
{"text": "rt AT_USER 'AT_USER tells us he's not looking at gilead $gild"}
{"text": "rt AT_USER $gild ceo r&amp;d portion of #jpm17 presentation heavy on nash pipeline."}
{"text": "gilead: grow the dividend, cut the buybacks $gild URL"}
{"text": "'AT_USER tells us he's not looking at gilead $gild"}
{"text": "icahn is \"not looking at gilead.\" would not revisit/buy apple here; only if it went \"much lower.\" AT_USER $gild $aapl"}
{"text": "rt AT_USER $gild ceo hiv talk heavy on bictegravir (in ph3, results mid 2017) and truvada prep. (bigger focus now) #jpm17"}
{"text": "gilead sciences - top biotech pick for the next decade URL $gild"}
{"text": "rt AT_USER $gild's milligan: hcv is a franchise where we cure people and they exit the healthcare system #jpm17"}
{"text": "#gileadsciences brief-gilead coo says slowdown in patients starting hep c therapies to cont... read more: URL $gild"}
{"text": "rt AT_USER $gild to start 2 phase iii studies in #nash with selonsertib, targeting f3 and f4 patients #jpm17"}
{"text": "rt AT_USER that's a wrap for AT_USER &amp; me for day 1 @ #jpm17. live tomorrow AT_USER ceos of $ilmn $athn $regn $vrx $agn $shpg $es\u00a1\u00ad"}
{"text": "rt AT_USER that's a wrap for AT_USER &amp; me for day 1 @ #jpm17. live tomorrow AT_USER ceos of $ilmn $athn $regn $vrx $agn $shpg $es\u00a1\u00ad"}
{"text": "rt AT_USER that's a wrap for AT_USER &amp; me for day 1 @ #jpm17. live tomorrow AT_USER ceos of $ilmn $athn $regn $vrx $agn $shpg $es\u00a1\u00ad"}
{"text": "that's a wrap for AT_USER &amp; me for day 1 @ #jpm17. live tomorrow AT_USER ceos of $ilmn $athn $regn $vrx $agn $shpg $esrx $edit $myl $gild"}
{"text": "captisol-enabled gs-5734 highlighted by $gild at #jpm17 URL"}
{"text": "brief-#gileadsciences planning phase iii nash trials. read more: URL $gild"}
{"text": "possible bottom forming on gilead's chart $gild ?? sort of held $72 three times now. wouldn't move till\u00a1\u00ad URL"}
{"text": "gilead sciences' (gild) ceo john milligan presents at 35th annual j.p. morgan healthcare co... URL $gild"}
{"text": "why ariad pharmaceuticals stock soared today: URL $aria $gild $tkphf"}
{"text": "great day for npp thanks to $xbi and $gild. we widened the gap further between us and the s&amp;p 500. URL"}
{"text": "#options #maxpain chart for $gild. free stock station app URL #itunes URL"}
{"text": "AT_USER monster run in $clvs ? $gild or $celg ?  what you thinking. could just be short covering , but what a run from low 30s to $51"}
{"text": "3 stocks to consider in canada pot market URL $aphqf $gild $ogrmf $twmjf"}
{"text": "rt AT_USER $srpt on highs, $gild trying to bounce, $eglt still halted, $spy hitting lows, $cc off highs"}
{"text": "rt AT_USER gilead $gild: #nash pipe targeting with nash with fibrosis ~3m patients in the us (f3-f4 stage)"}
{"text": "rt AT_USER $gild breakout. on oncology, milligan said \"insight\" twice referring to riva, new head of cancer business. insight = $i\u00a1\u00ad"}
{"text": "$gild #options oi chart. free stock station app URL #itunes URL"}
{"text": "gilead sciences\u00a1\u00af $gild \u00a1\u00b0buy\u00a1\u00b1 rating reaffirmed at cowen and company URL"}
{"text": "gilead sciences\u00a1\u00af $gild \u00a1\u00b0buy\u00a1\u00b1 rating reaffirmed at cowen and company URL"}
{"text": "rt AT_USER $srpt on highs, $gild trying to bounce, $eglt still halted, $spy hitting lows, $cc off highs"}
{"text": "$gild #options volume chart in animation. free stock station app URL #itunes URL"}
{"text": "rt AT_USER $gild's bischofberger: we're entertaining more expansion in oncology because of signif. scientific momentum. meeting 80+ cos.\u00a1\u00ad"}
{"text": "rt AT_USER $gild coo kevin young says hcv treatment patients starts will continue declining into 2017. not sure when equilibrium will co\u00a1\u00ad"}
{"text": "rt AT_USER $gild breakout. the full force of co.'s hiv power is being applied to bictegravir pgm. they sound really confident abou\u00a1\u00ad"}
{"text": "rt AT_USER how might new hiv shift market? $gild's young: \"we're really excited\" about hiv. genvoya has exceeded atripla in launch,\u00a1\u00ad"}
{"text": "AT_USER $gild does have most of the nash mechanisms covered"}
{"text": "AT_USER yep i agree, seems clear it will be in onco, i think parps are attractive,car t would be a really interesting flyer $gild #jmp17"}
{"text": "recent $gild technical alerts: stochastic reached overbought... URL"}
{"text": "rt AT_USER $gild coo kevin young says hcv treatment patients starts will continue declining into 2017. not sure when equilibrium will co\u00a1\u00ad"}
{"text": "rt AT_USER $gild's bischofberger: we're entertaining more expansion in oncology because of signif. scientific momentum. meeting 80+ cos.\u00a1\u00ad"}
{"text": "rt AT_USER $gild was moved from grand ballroom because biden is here, speaking. #jpm17"}
{"text": "rt AT_USER $gild was moved from grand ballroom because biden is here, speaking. #jpm17"}
{"text": "$gild - annual statement of changes in beneficial ownership (5) URL"}
{"text": "rt AT_USER $gild coo kevin young says hcv treatment patients starts will continue declining into 2017. not sure when equilibrium will co\u00a1\u00ad"}
{"text": "rt AT_USER $gild's bischofberger: we're entertaining more expansion in oncology because of signif. scientific momentum. meeting 80+ cos.\u00a1\u00ad"}
{"text": "rt AT_USER $srpt on highs, $gild trying to bounce, $eglt still halted, $spy hitting lows, $cc off highs"}
{"text": "$srpt on highs, $gild trying to bounce, $eglt still halted, $spy hitting lows, $cc off highs"}
{"text": "gilead sciences's chief operating officer just picked up 444 shares  URL $gild"}
{"text": "rt AT_USER sounds like $gild desperately needs deal advocates, and it is only because one existed that pharmasset happened. #yeswec\u00a1\u00ad"}
{"text": "$dvax, $srpt, $vrx, $teva, $gild, $xbi. $aria is bought. great news will come out from the #jpmhc35"}
{"text": "#calithera pharma in focus, part 3 - arginase inhibitor and #acquisition target $cala also $gild $bmy $amgn $fprx URL"}
{"text": "rt AT_USER $gild was moved from grand ballroom because biden is here, speaking. #jpm17"}
{"text": "bioworld today: $gild's bischofberger: we're entertaining more expansion in oncology because of signif.\u00a1\u00ad\u00a1\u00ad URL"}
{"text": "gilead: grow the dividend, cut the buybacks URL $glpg $gild"}
{"text": "gilead: grow the dividend, cut the buybacks URL $glpg $gild"}
{"text": "gilead: grow the dividend, cut the buybacks URL $glpg $gild"}
{"text": "$gild chart URL via URL"}
{"text": "rt AT_USER milligan: the pbms have created this system where there are enormous gross to nets, which works to their advantage. #jpm\u00a1\u00ad"}
{"text": "rt AT_USER $gild was moved from grand ballroom because biden is here, speaking. #jpm17"}
{"text": "it's all based off of their 2016 performance.  they've been sent to sit in the corner.  $gild URL"}
{"text": "rt AT_USER young: the va has been a very powerful driver of patient starts in hcv. $gild"}
{"text": "adamfeuerstein: $gild was moved from grand ballroom because biden is here, speaking. #jpm17"}
{"text": "rt AT_USER \"we need to talk about copay escalation\" says $gild on question on pricing issue. also says need to 'jointly own' issue\u00a1\u00ad"}
{"text": "rt AT_USER milligan talking about copay escalation. \"that has been the pain point for patients.\" $gild #jpm17"}
{"text": "$gild to lows, $ibb hanging around highs of the day just below $284"}
{"text": "rt AT_USER milligan talking about copay escalation. \"that has been the pain point for patients.\" $gild #jpm17"}
{"text": "rt AT_USER $gild coo kevin young says hcv treatment patients starts will continue declining into 2017. not sure when equilibrium will co\u00a1\u00ad"}
{"text": "rt AT_USER milligan talking about copay escalation. \"that has been the pain point for patients.\" $gild #jpm17"}
{"text": "$gild was moved from grand ballroom because biden is here, speaking. #jpm17"}
{"text": "rt AT_USER $gild coo kevin young says hcv treatment patients starts will continue declining into 2017. not sure when equilibrium will co\u00a1\u00ad"}
{"text": "rt AT_USER milligan talking about copay escalation. \"that has been the pain point for patients.\" $gild #jpm17"}
{"text": "young: the va has been a very powerful driver of patient starts in hcv. $gild"}
{"text": "we need to talk about copay escalation\" says $gild on question on pricing issue. also says need to 'jointly own' issue with pbms. #jpm17"}
{"text": "milligan talking about copay escalation. \"that has been the pain point for patients.\" $gild #jpm17"}
{"text": "rt AT_USER milligan: the pbms have created this system where there are enormous gross to nets, which works to their advantage. #jpm\u00a1\u00ad"}
{"text": "rt AT_USER milligan: the pbms have created this system where there are enormous gross to nets, which works to their advantage. #jpm\u00a1\u00ad"}
{"text": "$gild waiting on 72 is like watching paint dry but that's where it goes"}
{"text": "rt AT_USER milligan: the pbms have created this system where there are enormous gross to nets, which works to their advantage. #jpm\u00a1\u00ad"}
{"text": "demanding acquisition asap by $gild won't yield max value. patience for right asset at right price. #jpm17 #jpmhc35"}
{"text": "milligan: the pbms have created this system where there are enormous gross to nets, which works to their advantage. #jpm17 $gild"}
{"text": "AT_USER one way to look at $gild pov on deals is that they're at not invented here co that's reluctantly done a number of key deals"}
{"text": "rt AT_USER medicare part d catastrophic coverage spending on pricey specialty drugs tripled.. report is here.. URL"}
{"text": "rt AT_USER $gild's bischofberger: we're entertaining more expansion in oncology because of signif. scientific momentum. meeting 80+ cos.\u00a1\u00ad"}
{"text": "rt AT_USER $gild coo kevin young says hcv treatment patients starts will continue declining into 2017. not sure when equilibrium will co\u00a1\u00ad"}
{"text": "$gild coo kevin young says hcv treatment patients starts will continue declining into 2017. not sure when equilibrium will come #jpmhc35"}
{"text": "young reminds suits that hcv still incredibly efficient, i.e., lots of $$$$$. $gild #jpm17"}
{"text": "rt AT_USER young acknowledges $gild has no control over slowing. says trying to push awareness with direct to patient campaigns. $g\u00a1\u00ad"}
{"text": "young acknowledges $gild has no control over slowing. says trying to push awareness with direct to patient campaigns. $gild #jpm17"}
{"text": "rt AT_USER $gild breakout. on oncology, milligan said \"insight\" twice referring to riva, new head of cancer business. insight = $i\u00a1\u00ad"}
{"text": "rt AT_USER $gild's milligan acknowledged need to fill the near-term pipeline. says alessandro may help get deals over the line. #jp\u00a1\u00ad"}
{"text": "rt AT_USER $gild's milligan acknowledged need to fill the near-term pipeline. says alessandro may help get deals over the line. #jp\u00a1\u00ad"}
{"text": "by far biggest factor in forecasting hep c are treatment starts -- over pricing. seeing a slowing. young says should continue in 17. $gild"}
{"text": "rt AT_USER $gild ceo r&amp;d portion of #jpm17 presentation heavy on nash pipeline."}
{"text": "rt AT_USER $gild's milligan acknowledged need to fill the near-term pipeline. says alessandro may help get deals over the line. #jp\u00a1\u00ad"}
